Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial.

tirzepatide 用於兒童及青少年第二型糖尿病之療效與安全性（SURPASS-PEDS）：一項隨機、雙盲、安慰劑對照、第三期臨床試驗